社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Wagyus
IP属地：未知
+关注
帖子 · 19
帖子 · 19
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Wagyus
Wagyus
·
2021-11-11
$AMD(AMD)$
K
看
568
回复
评论
点赞
1
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-09
$AMD(AMD)$
No no dont let me know
看
495
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-08
$AMD(AMD)$
Sheeeeesh
看
537
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-07
$Pfizer(PFE)$
Up up
看
389
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-06
$AMD(AMD)$
Happy birthday to me
看
711
回复
评论
点赞
2
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-06
$B. Riley Principal 150 Merger Corp(BRPM)$
Watching
看
590
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-05
Kk
28 Stocks Moving in Friday's Pre-Market Session
Gainers ReWalk Robotics Ltd. rose 65.8% to $2.14 in pre-market trading after the company announced
28 Stocks Moving in Friday's Pre-Market Session
看
586
回复
1
点赞
点赞
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-05
Cool
Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug wa
Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%
看
503
回复
评论
点赞
5
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-05
Ok
Tesla Stock Is Overvalued by $1 Trillion, Analyst Says. We Looked at the Math.
Tesla‘s market capitalization recently moved well past $1 trillion, but the independent investment-r
Tesla Stock Is Overvalued by $1 Trillion, Analyst Says. We Looked at the Math.
看
824
回复
1
点赞
5
编组 21备份 2
分享
举报
Wagyus
Wagyus
·
2021-11-04
$AMD(AMD)$
up up and awayyyyy
看
570
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4098347982407220","uuid":"4098347982407220","gmtCreate":1635256075480,"gmtModify":1635386162947,"name":"Wagyus","pinyin":"wagyus","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":55,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":870217453,"gmtCreate":1636621984824,"gmtModify":1636622921837,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>K","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>K","text":"$AMD(AMD)$K","images":[{"img":"https://static.tigerbbs.com/2a7775cceea492c4359ecc24bc1a5025","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870217453","isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844761338,"gmtCreate":1636461336165,"gmtModify":1636461382445,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>No no dont let me know","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>No no dont let me know","text":"$AMD(AMD)$No no dont let me know","images":[{"img":"https://static.tigerbbs.com/32cfa13edbafca59866d957d7dc3e987","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844761338","isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844975551,"gmtCreate":1636385640445,"gmtModify":1636385640592,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Sheeeeesh","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Sheeeeesh","text":"$AMD(AMD)$Sheeeeesh","images":[{"img":"https://static.tigerbbs.com/d2e2b97503d7df6feabe58eb69e6070f","width":"1125","height":"2452"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844975551","isVote":1,"tweetType":1,"viewCount":537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845371485,"gmtCreate":1636293826776,"gmtModify":1636293826895,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>Up up","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>Up up","text":"$Pfizer(PFE)$Up up","images":[{"img":"https://static.tigerbbs.com/b4ca0cb8946dd4a9b6da78818f9b8e2b","width":"1125","height":"2711"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845371485","isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842236896,"gmtCreate":1636178934005,"gmtModify":1636178934005,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Happy birthday to me","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Happy birthday to me","text":"$AMD(AMD)$Happy birthday to me","images":[{"img":"https://static.tigerbbs.com/9a1b652735cd2f7f28364d6bae46b8f0","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842236896","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842230352,"gmtCreate":1636178529654,"gmtModify":1636178529808,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BRPM\">$B. Riley Principal 150 Merger Corp(BRPM)$</a>Watching","listText":"<a href=\"https://laohu8.com/S/BRPM\">$B. Riley Principal 150 Merger Corp(BRPM)$</a>Watching","text":"$B. Riley Principal 150 Merger Corp(BRPM)$Watching","images":[{"img":"https://static.tigerbbs.com/f8c056b825191fa267520b385d3d99c8","width":"1125","height":"2711"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842230352","isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846739378,"gmtCreate":1636112385446,"gmtModify":1636112385588,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"Kk","listText":"Kk","text":"Kk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846739378","repostId":"1194740251","repostType":4,"repost":{"id":"1194740251","kind":"news","pubTimestamp":1636108715,"share":"https://www.laohu8.com/m/news/1194740251?lang=&edition=full","pubTime":"2021-11-05 18:38","market":"us","language":"en","title":"28 Stocks Moving in Friday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1194740251","media":"Benzinga","summary":"Gainers\n\nReWalk Robotics Ltd. rose 65.8% to $2.14 in pre-market trading after the company announced ","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>ReWalk Robotics Ltd.</b> rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough Device by the FDA.</li>\n <li><b>Ontrak, Inc.</b> rose 35.5% to $13.10 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 sales guidance.</li>\n <li><b>Assertio Holdings, Inc.</b> shares rose 28% to $1.42 in pre-market trading after the company posted upbeat quarterly results.</li>\n <li><b>Datadog, Inc.</b> rose 14.9% to $191.80 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.</li>\n <li><b>JFrog Ltd.</b> rose 13.4% to $40.20 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.</li>\n <li><b>Puxin Limited</b> rose 13.2% to $0.7020 in pre-market trading after gaining around 16% on Thursday.</li>\n <li><b>Borr Drilling Limited</b> rose 12.4% to $1.18 in pre-market trading after reporting preliminary results for the third quarter.</li>\n <li><b>Expedia Group, Inc.</b> shares rose 11.1% to $175.00 in pre-market trading as the company reported stronger-than-expected earnings and sales results for the third quarter on Thursday.</li>\n <li><b>Funko, Inc.</b> shares rose 9.4% to $19.05 in pre-market trading after the company reported upbeat Q3 earnings and issued strong FY21 forecast.</li>\n <li><b>Endo International plc</b> rose 9.3% to $5.40 in pre-market trading after the company posted strong Q3 results and raised FY21 forecast.</li>\n <li><b>Insignia Systems, Inc.</b> rose 8.2% to $8.02 in pre-market trading following Q3 results.</li>\n <li><b>Airbnb, Inc.</b> rose 7.6% to $192.00 in pre-market trading after the company reported its best quarter on record, with earnings and sales figures surpassing market expectations.</li>\n <li><b>Fluor Corporation</b> rose 6.7% to $21.64 in pre-market trading. Fluor stated that the Fluor Petrosea Joint Organization (FPJO) joint venture has been selected by PT Freeport Indonesia to install a new grinding mill at Grasberg copper and gold mining district in Papua, Indonesia.</li>\n <li><b>Novavax, Inc.</b> rose 5.4% to $189.00 in pre-market trading after reporting quarterly results.</li>\n <li><b>Pinterest, Inc.</b> rose 6% to $46.25 in pre-market trading following Q3 results. Pinterest reported upbeat results for its third quarter on Thursday. However, the company also posted a shortfall in monthly active users.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Evaxion Biotech A/S</b> fell 37.7% to $7.90 in pre-market trading after jumping 95% on Thursday.</li>\n <li><b>NRx Pharmaceuticals, Inc.</b> fell 35.1% to $5.79 in pre-market trading after the company said the FDA declined emergency use authorization for ZYESAMI for patients with critical COVID-19 with respiratory failure.</li>\n <li><b>Peloton Interactive, Inc.</b> shares fell 32.9% to $57.74 in pre-market trading after the company reported worse-than-expected Q1 results and issued FY22 sales guidance below estimates.</li>\n <li><b>bluebird bio, Inc.</b> shares fell 28.5% to $18.00 in pre-market trading. bluebird completed the tax-free spin-off of its oncology programs and portfolio into 2seventy bio, Inc.</li>\n <li><b>Puma Biotechnology, Inc.</b> shares fell 19.4% to $5.15 in pre-market trading after reporting a loss for the third quarter.</li>\n <li><b>TDH Holdings, Inc.</b> fell 15% to $3.62 in pre-market trading. TDH Holdings shares jumped around 80% on Thursday after the company announced it entered into a securities purchase agreement for a registered direct offering and closed the offering, raising $9.9 million in gross proceeds from the sale.</li>\n <li><b>Chembio Diagnostics, Inc.</b> fell 12.2% to $2.15 in pre-market trading after reporting a wider-than-expected quarterly loss.</li>\n <li><b>Aditxt, Inc.</b> shares fell 10.4% to $2.25 in pre-market trading after surging 36% on Thursday.</li>\n <li><b>Dynavax Technologies Corporation</b> fell 9% to $18.89 in pre-market trading after reporting a loss for the third quarter.</li>\n <li><b>Redbox Entertainment Inc.</b> fell 8% to $16.50 in pre-market trading after surging 45% on Thursday.</li>\n <li><b>Bloom Energy Corporation</b> fell 6.5% to $28.20 in pre-market trading after the company reported a wider-than-expected quarterly loss.</li>\n <li><b>First Solar, Inc.</b> shares fell 5.7% to $110.00 in pre-market trading after the company reported Q3 results.</li>\n <li><b>Square, Inc.</b> shares fell 4.4% to $236.70 in pre-market trading after reporting Q3 results.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>28 Stocks Moving in Friday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n28 Stocks Moving in Friday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 18:38 GMT+8 <a href=https://www.benzinga.com/news/21/11/23917789/28-stocks-moving-in-fridays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nReWalk Robotics Ltd. rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough Device by the FDA.\nOntrak, Inc. ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/23917789/28-stocks-moving-in-fridays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/news/21/11/23917789/28-stocks-moving-in-fridays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194740251","content_text":"Gainers\n\nReWalk Robotics Ltd. rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough Device by the FDA.\nOntrak, Inc. rose 35.5% to $13.10 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 sales guidance.\nAssertio Holdings, Inc. shares rose 28% to $1.42 in pre-market trading after the company posted upbeat quarterly results.\nDatadog, Inc. rose 14.9% to $191.80 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.\nJFrog Ltd. rose 13.4% to $40.20 in pre-market trading after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.\nPuxin Limited rose 13.2% to $0.7020 in pre-market trading after gaining around 16% on Thursday.\nBorr Drilling Limited rose 12.4% to $1.18 in pre-market trading after reporting preliminary results for the third quarter.\nExpedia Group, Inc. shares rose 11.1% to $175.00 in pre-market trading as the company reported stronger-than-expected earnings and sales results for the third quarter on Thursday.\nFunko, Inc. shares rose 9.4% to $19.05 in pre-market trading after the company reported upbeat Q3 earnings and issued strong FY21 forecast.\nEndo International plc rose 9.3% to $5.40 in pre-market trading after the company posted strong Q3 results and raised FY21 forecast.\nInsignia Systems, Inc. rose 8.2% to $8.02 in pre-market trading following Q3 results.\nAirbnb, Inc. rose 7.6% to $192.00 in pre-market trading after the company reported its best quarter on record, with earnings and sales figures surpassing market expectations.\nFluor Corporation rose 6.7% to $21.64 in pre-market trading. Fluor stated that the Fluor Petrosea Joint Organization (FPJO) joint venture has been selected by PT Freeport Indonesia to install a new grinding mill at Grasberg copper and gold mining district in Papua, Indonesia.\nNovavax, Inc. rose 5.4% to $189.00 in pre-market trading after reporting quarterly results.\nPinterest, Inc. rose 6% to $46.25 in pre-market trading following Q3 results. Pinterest reported upbeat results for its third quarter on Thursday. However, the company also posted a shortfall in monthly active users.\n\nLosers\n\nEvaxion Biotech A/S fell 37.7% to $7.90 in pre-market trading after jumping 95% on Thursday.\nNRx Pharmaceuticals, Inc. fell 35.1% to $5.79 in pre-market trading after the company said the FDA declined emergency use authorization for ZYESAMI for patients with critical COVID-19 with respiratory failure.\nPeloton Interactive, Inc. shares fell 32.9% to $57.74 in pre-market trading after the company reported worse-than-expected Q1 results and issued FY22 sales guidance below estimates.\nbluebird bio, Inc. shares fell 28.5% to $18.00 in pre-market trading. bluebird completed the tax-free spin-off of its oncology programs and portfolio into 2seventy bio, Inc.\nPuma Biotechnology, Inc. shares fell 19.4% to $5.15 in pre-market trading after reporting a loss for the third quarter.\nTDH Holdings, Inc. fell 15% to $3.62 in pre-market trading. TDH Holdings shares jumped around 80% on Thursday after the company announced it entered into a securities purchase agreement for a registered direct offering and closed the offering, raising $9.9 million in gross proceeds from the sale.\nChembio Diagnostics, Inc. fell 12.2% to $2.15 in pre-market trading after reporting a wider-than-expected quarterly loss.\nAditxt, Inc. shares fell 10.4% to $2.25 in pre-market trading after surging 36% on Thursday.\nDynavax Technologies Corporation fell 9% to $18.89 in pre-market trading after reporting a loss for the third quarter.\nRedbox Entertainment Inc. fell 8% to $16.50 in pre-market trading after surging 45% on Thursday.\nBloom Energy Corporation fell 6.5% to $28.20 in pre-market trading after the company reported a wider-than-expected quarterly loss.\nFirst Solar, Inc. shares fell 5.7% to $110.00 in pre-market trading after the company reported Q3 results.\nSquare, Inc. shares fell 4.4% to $236.70 in pre-market trading after reporting Q3 results.","news_type":1},"isVote":1,"tweetType":1,"viewCount":586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846797450,"gmtCreate":1636112222386,"gmtModify":1636112284565,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846797450","repostId":"1168526565","repostType":4,"repost":{"id":"1168526565","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636109309,"share":"https://www.laohu8.com/m/news/1168526565?lang=&edition=full","pubTime":"2021-11-05 18:48","market":"us","language":"en","title":"Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168526565","media":"Tiger Newspress","summary":"A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug wa","content":"<p>A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.</p>\n<p>The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.</p>\n<p>Full trial data is not yet available from either company.</p>\n<p>Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, to the U.S. Food and Drug Administration as part of the emergency use application it opened in October.</p>\n<p>The combination treatment, which will have the brand name Paxlovid, consists of three pills given twice daily.</p>\n<p>The planned analysis of 1,219 patients in Pfizer's study looked at hospitalizations or deaths among people diagnosed with mild to moderate COVID-19 with at least one risk factor for developing severe disease, such as obesity or older age.</p>\n<p>It found that 0.8% of those given Pfizer's drug within three days of symptom onset were hospitalized and none had died by 28 days after treatment. That compared with a hospitalization rate of 7% for placebo patients. There were also seven deaths in the placebo group.</p>\n<p>Rates were similar for patients treated within five days of symptoms - 1% of the treatment group was hospitalized, compared with 6.7% for the placebo group, which included 10 deaths.</p>\n<p>Antivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.</p>\n<p>\"We saw that we did have high efficacy, even if it was five days after a patient has been treated ... people might wait a couple of days before getting a test or something, and this means that we have time to treat people and really provide a benefit from a public health perspective,\" Annaliesa Anderson, head of the Pfizer program, told Reuters.</p>\n<p>The company did not detail side effects of the treatment, but said adverse events happened in about 20% of both treatment and placebo patients.</p>\n<p>\"These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” Pfizer Chief Executive Albert Bourla said in a statement.</p>\n<p>Infectious disease experts stress that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic, but only 58% of Americans are fully vaccinated and access in many parts of the world is limited.</p>\n<p>Pfizer's drug, part of a class known as protease inhibitors, is designed to block an enzyme the coronavirus needs in order to multiply.</p>\n<p>Merck's molnupiravir has a different mechanism of action designed to introduce errors into the genetic code of the virus. Merck has already sold millions of courses of the treatment, which was approved this week by U.K. regulators, to the United States, the U.K. and others.</p>\n<p>Britain said earlier this month it had secured 250,000 courses of Pfizer's antiviral.</p>\n<p>Pfizer is also studying whether its pill could be used by people without risk factors for serious COVID-19 as well as to prevent coronavirus infection in people exposed to the virus.</p>\n<p>Its shares rose over 9% in premarket trading.<img src=\"https://static.tigerbbs.com/190a24394aa60d689cf29552569f5e20\" tg-width=\"774\" tg-height=\"567\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer rose over 9% in premarket trading as its antiviral pill cut risk of severe COVID-19 by 89%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 18:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.</p>\n<p>The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.</p>\n<p>Full trial data is not yet available from either company.</p>\n<p>Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, to the U.S. Food and Drug Administration as part of the emergency use application it opened in October.</p>\n<p>The combination treatment, which will have the brand name Paxlovid, consists of three pills given twice daily.</p>\n<p>The planned analysis of 1,219 patients in Pfizer's study looked at hospitalizations or deaths among people diagnosed with mild to moderate COVID-19 with at least one risk factor for developing severe disease, such as obesity or older age.</p>\n<p>It found that 0.8% of those given Pfizer's drug within three days of symptom onset were hospitalized and none had died by 28 days after treatment. That compared with a hospitalization rate of 7% for placebo patients. There were also seven deaths in the placebo group.</p>\n<p>Rates were similar for patients treated within five days of symptoms - 1% of the treatment group was hospitalized, compared with 6.7% for the placebo group, which included 10 deaths.</p>\n<p>Antivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.</p>\n<p>\"We saw that we did have high efficacy, even if it was five days after a patient has been treated ... people might wait a couple of days before getting a test or something, and this means that we have time to treat people and really provide a benefit from a public health perspective,\" Annaliesa Anderson, head of the Pfizer program, told Reuters.</p>\n<p>The company did not detail side effects of the treatment, but said adverse events happened in about 20% of both treatment and placebo patients.</p>\n<p>\"These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” Pfizer Chief Executive Albert Bourla said in a statement.</p>\n<p>Infectious disease experts stress that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic, but only 58% of Americans are fully vaccinated and access in many parts of the world is limited.</p>\n<p>Pfizer's drug, part of a class known as protease inhibitors, is designed to block an enzyme the coronavirus needs in order to multiply.</p>\n<p>Merck's molnupiravir has a different mechanism of action designed to introduce errors into the genetic code of the virus. Merck has already sold millions of courses of the treatment, which was approved this week by U.K. regulators, to the United States, the U.K. and others.</p>\n<p>Britain said earlier this month it had secured 250,000 courses of Pfizer's antiviral.</p>\n<p>Pfizer is also studying whether its pill could be used by people without risk factors for serious COVID-19 as well as to prevent coronavirus infection in people exposed to the virus.</p>\n<p>Its shares rose over 9% in premarket trading.<img src=\"https://static.tigerbbs.com/190a24394aa60d689cf29552569f5e20\" tg-width=\"774\" tg-height=\"567\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168526565","content_text":"A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.\nThe results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness.\nFull trial data is not yet available from either company.\nPfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, to the U.S. Food and Drug Administration as part of the emergency use application it opened in October.\nThe combination treatment, which will have the brand name Paxlovid, consists of three pills given twice daily.\nThe planned analysis of 1,219 patients in Pfizer's study looked at hospitalizations or deaths among people diagnosed with mild to moderate COVID-19 with at least one risk factor for developing severe disease, such as obesity or older age.\nIt found that 0.8% of those given Pfizer's drug within three days of symptom onset were hospitalized and none had died by 28 days after treatment. That compared with a hospitalization rate of 7% for placebo patients. There were also seven deaths in the placebo group.\nRates were similar for patients treated within five days of symptoms - 1% of the treatment group was hospitalized, compared with 6.7% for the placebo group, which included 10 deaths.\nAntivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.\n\"We saw that we did have high efficacy, even if it was five days after a patient has been treated ... people might wait a couple of days before getting a test or something, and this means that we have time to treat people and really provide a benefit from a public health perspective,\" Annaliesa Anderson, head of the Pfizer program, told Reuters.\nThe company did not detail side effects of the treatment, but said adverse events happened in about 20% of both treatment and placebo patients.\n\"These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” Pfizer Chief Executive Albert Bourla said in a statement.\nInfectious disease experts stress that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic, but only 58% of Americans are fully vaccinated and access in many parts of the world is limited.\nPfizer's drug, part of a class known as protease inhibitors, is designed to block an enzyme the coronavirus needs in order to multiply.\nMerck's molnupiravir has a different mechanism of action designed to introduce errors into the genetic code of the virus. Merck has already sold millions of courses of the treatment, which was approved this week by U.K. regulators, to the United States, the U.K. and others.\nBritain said earlier this month it had secured 250,000 courses of Pfizer's antiviral.\nPfizer is also studying whether its pill could be used by people without risk factors for serious COVID-19 as well as to prevent coronavirus infection in people exposed to the virus.\nIts shares rose over 9% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846794274,"gmtCreate":1636112109998,"gmtModify":1636112276681,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846794274","repostId":"1180620689","repostType":4,"repost":{"id":"1180620689","kind":"news","pubTimestamp":1636112077,"share":"https://www.laohu8.com/m/news/1180620689?lang=&edition=full","pubTime":"2021-11-05 19:34","market":"us","language":"en","title":"Tesla Stock Is Overvalued by $1 Trillion, Analyst Says. We Looked at the Math.","url":"https://stock-news.laohu8.com/highlight/detail?id=1180620689","media":"Barrons","summary":"Tesla‘s market capitalization recently moved well past $1 trillion, but the independent investment-r","content":"<p>Tesla‘s market capitalization recently moved well past $1 trillion, but the independent investment-research firm New Constructs believes the company is overvalued by roughly $1 trillion of that. The firm’s CEO, David Trainer, says Tesla shares could fall as much as 88%, to roughly $150 a share.</p>\n<p>His argument, which isn’t the first extreme bear or bull case Tesla (ticker: TSLA) investors have had to weigh, is mainly based on math.</p>\n<p>Tesla stock, which has risen about 57% over the past month, was little changed in premarket trading Friday after gaining up 1.3% Thursday afternoon, while the S&P 500 advanced 0.4% and the Dow Jones Industrial Average finished off 0.1%. Strong third-quarter deliveries, earnings, and a sale of 100,000 vehicles to the rental-car company Hertz (HTZZ) have sent the stock through the roof.</p>\n<p>Today, Tesla is worth roughly $1.2 trillion–a figure Trainer says makes no sense. Tesla didn’t immediately respond to a request for comment.</p>\n<p>“The $1.2 trillion valuation implies Tesla owns 118% of the entire global passenger EV market and becomes more profitable than Apple [AAPL] by 2030,” wrote Trainer in a Thursday report. His work looked at what kind of sales and earnings the company would have to achieve to be worth that much.</p>\n<p>Trainer believes Tesla would have to sell almost 31 million vehicles in 2030 to justify the current valuation. That is more than he expects the entire industry to produce, based on figures from the International Energy Agency. The base case in the IEA’s 2021 outlook for electric vehicles projects annual global sales of about 28 million EVs at the end of the decade.</p>\n<p>To be sure, that IEA report was published in April, before many auto makers committed to spending billions of dollars on vehicle electrification and battery-production capacity. It was in August that President Joe Biden announced his <a href=\"https://www.marketwatch.com/articles/tesla-musk-biden-ev-stock-51628202850\" target=\"_blank\">goal for EVs</a> to account for 50% of new-car sales by 2030. And the IEA report includes a best-case scenario with about 47 million EVs sold around the world annually by 2030.</p>\n<p>There are, of course, Tesla bulls, and most of them don’t believe Tesla is going to sell 31 million cars a year by 2030. Morgan Stanley’s Adam Jonas, who rates the stock at Buy and has a $1,200 price target for shares, predicts annual sales of about 8 million units by then.</p>\n<p>Jonas believes Tesla will be more profitable than traditional auto makers. But Trainer assumes that Tesla will have operating profit margins in line with those of General Motors (GM). With 31 million vehicles sold, that might mean Tesla earns $131 billion in 2030 operating profit, higher than the $100 billion-plus Apple is pulling in now, he said.</p>\n<p>But if Jonas’s call for Tesla to sell 8 million vehicles in 2030 is correct, Trainer said, that would yield earnings of about $30 billion annually, assuming Elon Musk’s company only matches GM’s net operating after-tax profit margin of 8.5%.</p>\n<p>Recently, of course, some of Tesla’s profit margins have been industry-leading, which is no surprise given the popularity of the vehicles and the fact that the company doesn’t have the pension obligations its older rivals face. Third-quarter gross margins exceeded GM’s,Ford Motor‘s (F), and Volkswagen’s (VOW3. Germany), to name a few.</p>\n<p>Longer-term margins are hard to predict, though Trainer told <i>Barron’s</i> he thinks his assumption is fair. They depend on factors such as software sales—all auto makers are offering software-enabled features that can be sold on subscriptions—as well as battery costs.</p>\n<p>“Putting it all together: Tesla provides poor risk/reward,” Trainer wrote.</p>\n<p>His arguments are unlikely to sway the many bulls who follow the stock. There are 14 analysts, almost one-third of the 44 Bloomberg tracks, with target prices that value Tesla at $1 trillion or more.</p>\n<p>The bulls believe Tesla is the EV leader and will increase its sales and production volume at 50% a year on average for the foreseeable future. They also believe EVs will be more profitable than traditional vehicles and that Tesla will maintain its cost leadership. Many bulls also believe that Tesla’s power-storage business, plus a robotaxi operation it could launch if it succeeds in developing self-driving cars, will generate significant sales.</p>\n<p>Time will tell who is right. The bulls are feeling good these days given Tesla’s strong results. And the bears are staring agape at the stock’s valuation, which essentially matches all of the world’s traditional auto makers combined.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Is Overvalued by $1 Trillion, Analyst Says. We Looked at the Math.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Is Overvalued by $1 Trillion, Analyst Says. We Looked at the Math.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 19:34 GMT+8 <a href=https://www.barrons.com/articles/tesla-stock-overvalued-1-trillion-51636053056?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla‘s market capitalization recently moved well past $1 trillion, but the independent investment-research firm New Constructs believes the company is overvalued by roughly $1 trillion of that. The ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-overvalued-1-trillion-51636053056?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-overvalued-1-trillion-51636053056?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180620689","content_text":"Tesla‘s market capitalization recently moved well past $1 trillion, but the independent investment-research firm New Constructs believes the company is overvalued by roughly $1 trillion of that. The firm’s CEO, David Trainer, says Tesla shares could fall as much as 88%, to roughly $150 a share.\nHis argument, which isn’t the first extreme bear or bull case Tesla (ticker: TSLA) investors have had to weigh, is mainly based on math.\nTesla stock, which has risen about 57% over the past month, was little changed in premarket trading Friday after gaining up 1.3% Thursday afternoon, while the S&P 500 advanced 0.4% and the Dow Jones Industrial Average finished off 0.1%. Strong third-quarter deliveries, earnings, and a sale of 100,000 vehicles to the rental-car company Hertz (HTZZ) have sent the stock through the roof.\nToday, Tesla is worth roughly $1.2 trillion–a figure Trainer says makes no sense. Tesla didn’t immediately respond to a request for comment.\n“The $1.2 trillion valuation implies Tesla owns 118% of the entire global passenger EV market and becomes more profitable than Apple [AAPL] by 2030,” wrote Trainer in a Thursday report. His work looked at what kind of sales and earnings the company would have to achieve to be worth that much.\nTrainer believes Tesla would have to sell almost 31 million vehicles in 2030 to justify the current valuation. That is more than he expects the entire industry to produce, based on figures from the International Energy Agency. The base case in the IEA’s 2021 outlook for electric vehicles projects annual global sales of about 28 million EVs at the end of the decade.\nTo be sure, that IEA report was published in April, before many auto makers committed to spending billions of dollars on vehicle electrification and battery-production capacity. It was in August that President Joe Biden announced his goal for EVs to account for 50% of new-car sales by 2030. And the IEA report includes a best-case scenario with about 47 million EVs sold around the world annually by 2030.\nThere are, of course, Tesla bulls, and most of them don’t believe Tesla is going to sell 31 million cars a year by 2030. Morgan Stanley’s Adam Jonas, who rates the stock at Buy and has a $1,200 price target for shares, predicts annual sales of about 8 million units by then.\nJonas believes Tesla will be more profitable than traditional auto makers. But Trainer assumes that Tesla will have operating profit margins in line with those of General Motors (GM). With 31 million vehicles sold, that might mean Tesla earns $131 billion in 2030 operating profit, higher than the $100 billion-plus Apple is pulling in now, he said.\nBut if Jonas’s call for Tesla to sell 8 million vehicles in 2030 is correct, Trainer said, that would yield earnings of about $30 billion annually, assuming Elon Musk’s company only matches GM’s net operating after-tax profit margin of 8.5%.\nRecently, of course, some of Tesla’s profit margins have been industry-leading, which is no surprise given the popularity of the vehicles and the fact that the company doesn’t have the pension obligations its older rivals face. Third-quarter gross margins exceeded GM’s,Ford Motor‘s (F), and Volkswagen’s (VOW3. Germany), to name a few.\nLonger-term margins are hard to predict, though Trainer told Barron’s he thinks his assumption is fair. They depend on factors such as software sales—all auto makers are offering software-enabled features that can be sold on subscriptions—as well as battery costs.\n“Putting it all together: Tesla provides poor risk/reward,” Trainer wrote.\nHis arguments are unlikely to sway the many bulls who follow the stock. There are 14 analysts, almost one-third of the 44 Bloomberg tracks, with target prices that value Tesla at $1 trillion or more.\nThe bulls believe Tesla is the EV leader and will increase its sales and production volume at 50% a year on average for the foreseeable future. They also believe EVs will be more profitable than traditional vehicles and that Tesla will maintain its cost leadership. Many bulls also believe that Tesla’s power-storage business, plus a robotaxi operation it could launch if it succeeds in developing self-driving cars, will generate significant sales.\nTime will tell who is right. The bulls are feeling good these days given Tesla’s strong results. And the bears are staring agape at the stock’s valuation, which essentially matches all of the world’s traditional auto makers combined.","news_type":1},"isVote":1,"tweetType":1,"viewCount":824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848643973,"gmtCreate":1635996931682,"gmtModify":1635996942673,"author":{"id":"4098347982407220","authorId":"4098347982407220","name":"Wagyus","avatar":"https://static.tigerbbs.com/4a3ff8b27069df31bfda9c2867aef32f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098347982407220","authorIdStr":"4098347982407220"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>up up and awayyyyy","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>up up and awayyyyy","text":"$AMD(AMD)$up up and awayyyyy","images":[{"img":"https://static.tigerbbs.com/d3bd3c199034386c2b63a6d8ad9d1719","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848643973","isVote":1,"tweetType":1,"viewCount":570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}